During the past decade, New Bern Cancer Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Bern Cancer Care" #1 sponsor was "Radiation Therapy Oncology Group" with 2 trials, followed by "Celgene" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored, "Coastal Carolina Radiation Oncology" with 1 trials sponsored and "Spectrum Pharmaceuticals, Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Bern Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "New Hanover Regional Medical Center" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "New Bern Cancer Care" are "Prostate Cancer" (3 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Gastric Cancer" (1 trials), "Head and Neck Cancer" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "New Bern Cancer Care" in a lesser frequency.

Most popular intervention types in "New Bern Cancer Care" are "Drug" (6 trials), "Radiation" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-FU/cisplatin" (1 trials), "AA" (1 trials), "Brachytherapy (100/110)" (1 trials), "Brachytherapy (125/145)" (1 trials) and "CC-5013 (lenalidomide)" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Bern Cancer Care" are 4 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "New Bern Cancer Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in New Bern Cancer Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Bern Cancer Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".